Publications

Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E, Herault A, Saric J, Belghiti J, Franco D et al..  2007.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology. 45:42-52. Abstract

Pilati C, Amessou M, Bihl MP, Balabaud C, Van Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G et al..  2011.  Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. Journal of Experimental Medicine. 208(668932323254529112661614395143715772267205211193251553):1359-1366. Abstract

Rousseau B, Menard L, Haurie V, Taras D, Blanc JF, Moreau-Gaudry F, Metzler P, Hugues M, Boyault S, Lemiere S et al..  2007.  Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology. 46:1108-18. Abstract

Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.  2008.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology. 47:1955-63. Abstract

Pelletier L, Rebouissou S, Paris A, Rathahao-Paris E, Perdu E, Bioulac-Sage P, Imbeaud S, Zucman-Rossi J.  2010.  Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology. 51:557-66. Abstract

Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H.  2008.  Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 48:808-18. Abstract

Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S et al..  2007.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 46:740-8. Abstract

Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc JF, Cubel G, Trillaud H et al..  2009.  Hepatocellular adenoma management and phenotypic classification: The bordeaux experience. Hepatology. Abstract

Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S et al..  2006.  Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 43:515-24. Abstract

Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J.  2007.  Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol. 13:2649-54. Abstract

Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P, Zucman-Rossi J.  2001.  Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology. 120:1763-73.. Abstract

Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J.  2009.  Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 457:200-4. Abstract

Bacq Y, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau S, Laurent C, Bourlier P, Pariente D, de Muret A et al..  2003.  Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology. 125:1470-5. Abstract